MobiHealth News November 30, 2021
Fiona Keating

The long-term strategic partnership between Ada Health and Bayer will empower individuals to take greater ownership of their personal health and make informed decisions.

The partnership will help visitors to Bayer websites for Aspirin, Aleve, Midol, Cenesten and Iberogast to access Ada’s intelligent symptom assessment platform.

Using an AI-based health assessment platform, Berlin-based Ada Health assists users in identifying the correct care, based on their individual requirements, risk factors and symptoms.

The free app provides guidance via an AI chatbot which asks users targeted questions that generate data-driven options and suggestions for the next steps in seeking healthcare.

WHY IT MATTERS

The partnership offers a digital solution so that people can be more proactive about preventative healthcare.

Digital health tools...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Trends
How healthcare's view of AI has shifted
The Power of Drug Discovery with Philip Tagari
Bite-Sized AI: Why Smaller Models Like Microsoft’s Phi-3 Are Big for Business
Coventry Uni uses AI-generated avatars to train medical students
Lessons on generative AI in medicine from Stanford University

Share This Article